Japan Medical Dynamic Marketing INC
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices t… Read more
Japan Medical Dynamic Marketing INC (JMD) - Total Assets
Latest total assets as of September 2025: €32.68 Billion EUR
Based on the latest financial reports, Japan Medical Dynamic Marketing INC (JMD) holds total assets worth €32.68 Billion EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Japan Medical Dynamic Marketing INC - Total Assets Trend (2014–2025)
This chart illustrates how Japan Medical Dynamic Marketing INC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Japan Medical Dynamic Marketing INC - Asset Composition Analysis
Current Asset Composition (March 2025)
Japan Medical Dynamic Marketing INC's total assets of €32.68 Billion consist of 70.9% current assets and 29.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 9.5% |
| Accounts Receivable | €6.13 Billion | 18.2% |
| Inventory | €13.89 Billion | 41.3% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Japan Medical Dynamic Marketing INC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Japan Medical Dynamic Marketing INC's current assets represent 70.9% of total assets in 2025, an increase from 56.8% in 2014.
- Cash Position: Cash and equivalents constituted 9.5% of total assets in 2025, down from 10.5% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 41.3% of total assets.
Japan Medical Dynamic Marketing INC Competitors by Total Assets
Key competitors of Japan Medical Dynamic Marketing INC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Japan Medical Dynamic Marketing INC - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Japan Medical Dynamic Marketing INC generates 0.75x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Japan Medical Dynamic Marketing INC is currently not profitable relative to its asset base.
Japan Medical Dynamic Marketing INC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.06 | 4.82 | 4.97 |
| Quick Ratio | 1.40 | 1.82 | 1.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €17.28 Billion | € 17.09 Billion | € 12.32 Billion |
Japan Medical Dynamic Marketing INC - Advanced Valuation Insights
This section examines the relationship between Japan Medical Dynamic Marketing INC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.49 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.9% |
| Total Assets | €33.67 Billion |
| Market Capitalization | $43.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values Japan Medical Dynamic Marketing INC's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Japan Medical Dynamic Marketing INC's assets grew by 6.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Japan Medical Dynamic Marketing INC (2014–2025)
The table below shows the annual total assets of Japan Medical Dynamic Marketing INC from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | €33.67 Billion | +6.93% |
| 2024-03-31 | €31.49 Billion | +6.97% |
| 2023-03-31 | €29.43 Billion | +7.65% |
| 2022-03-31 | €27.34 Billion | +8.53% |
| 2021-03-31 | €25.19 Billion | +1.11% |
| 2020-03-31 | €24.92 Billion | +6.07% |
| 2019-03-31 | €23.49 Billion | +12.56% |
| 2018-03-31 | €20.87 Billion | -3.10% |
| 2017-03-31 | €21.54 Billion | +6.98% |
| 2016-03-31 | €20.13 Billion | -0.17% |
| 2015-03-31 | €20.17 Billion | +3.51% |
| 2014-03-31 | €19.48 Billion | -- |